Seres Therapeutics (MCRB) Misses Q3 EPS by 25c

Seres Therapeutics (NASDAQ: MCRB) reported Q3 EPS of ($0.33), $0.25 worse than the analyst estimate of ($0.08).

For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.

You May Also Be Interested In

• Assurant (AIZ) is Piper Sandler's Weekly Focus Idea
• Netflix (NFLX) call put ratio 2.3 calls to 1 put as share price down 3.4%
• Increasing unusual put volume: WMB SOC DFTX BFLY EQT STRC VTRC HIVE AS XRX NBIG GGAL TE CWVX SKM AGI UAA CMG